Gastric bypass prevents diabetes in genetically modified mice and chemically induced diabetic mice.
Obese subjects have increase probabilities of developing type 2 diabetes (T2D). In this study, we sought to determine whether gastric bypass prevents the progression of prediabetes to overt diabetes in genetically modified mice and chemically induced diabetic mice. Roux-en-Y gastric bypass (RYGB) wa...
Guardado en:
Autores principales: | Chenyu Zhu, Rui Xu, Yuxin Li, Michael Andrade, Deng Ping Yin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/48ed9b1aace84ddb83c25d8d48249702 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Gastric bypass prevents diabetes in genetically modified mice and chemically induced diabetic mice
por: Chenyu Zhu, et al.
Publicado: (2021) -
Prevention of pancreatic acinar cell carcinoma by Roux-en-Y Gastric Bypass Surgery
por: Rui He, et al.
Publicado: (2018) -
Prevention of cataract in diabetic mice by topical pyruvate
por: Hegde KR, et al.
Publicado: (2011) -
Immunization of AGE-modified albumin inhibits diabetic nephropathy progression in diabetic mice
por: Mashitah MW, et al.
Publicado: (2015) -
Tristetraprolin Prevents Gastric Metaplasia in Mice by Suppressing Pathogenic InflammationSummary
por: Jonathan T. Busada, et al.
Publicado: (2021)